Responses
Regular and young investigator award abstracts
Clinical trials in progress
348 A phase 2 umbrella study of retifanlimab (INCMGA00012) alone or in combination with other therapies in patients with advanced or metastatic endometrial cancer (POD1UM-204, GOG 3038, ENGOT-en12/NOGGO)
Compose a Response to This Article
Other responses
No responses have been published for this article.
